Aldeyra Therapeutics, Inc. · NASDAQ:ALDX
Perceptive Advisors LLC reported a 8.70% stake in Aldeyra Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Perceptive Advisors LLC reported a 8.70% stake in Aldeyra Therapeutics, Inc., 5,222,311 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 8.70%
- Shares
- 5,222,311
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 8.70% | 5,222,311 |
| Joseph Edelman | 8.70% | 5,222,311 |
| Perceptive Life Sciences Master Fund, Ltd. | 8.70% | 5,222,311 |
Source
Related
- Aldeyra Therapeutics, Inc.
- Perceptive Advisors LLC
- Aldeyra Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Feb 17, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Apr 7, 2025
- Schedule 13G · AQR Capital Management LLC · Aug 12, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Brady Todd C · Jun 5, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026